“…This is reinforced by the exceptional performance of deep learning models in histopathology image classification [1], [2], [3], [4], [5], [6], [7] and segmentation [8], [9], [10], [11] tasks. This high performance extends across a range of subjects of interest, including cancer [12], [13], [14], [15], [16], metastases [17], [18], [19], and gene mutation [20], [21], [22]. The exceptional performance and efficiency showcased by computational pathology using deep learning can effectively address the limitations of conventional HIA and provide valuable assistance to pathologists in their diagnostic tasks, thereby alleviating the burden on pathologists.…”